Abstract
To avoid host immune surveillance, human cytomegalovirus (HCMV) encoded endoplasmic reticulum (ER)-membrane glycoprotein US2, which interferes with antigen presenting mechanism of Major histocompatibility complex (MHC) class Ia and class II molecules. However, not many attempts have been made to study the effect of HCMV US2 on the expression of MHC class Ib molecules. In this study, we examined the effect of HCMV US2 on the expression and function of human CD1d (hCD1d), which presents glycolipid antigens to invariant NKT (iNKT) cells. Our results clearly showed that the physiological interaction between ER lumenal domain of HCMV US2 and α3 domain of hCD1d was observed within ER. Compared with mature form of hCD1d, immature form of hCD1d is more susceptible to ubiquitin-dependent proteasomal degradation mediated by HCMV US2. Moreover, the ectopic expression of HCMV US2 leads to the down-modulation of iNKT cell activity without significant change of hCD1d expression. These results will advance our understanding of the function of HCMV US2 in immune evasive mechanisms against anti-viral immunity of iNKT cells.
Similar content being viewed by others
References
Balk, S.P., Burke, S., Polischuk, J.E., Frantz, M.E., Yang, L., Porcelli, S., Colgan, S.P., and Blumberg, R.S. (1994). β2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265, 259–262.
Bendelac, A., Savage, P.B., and Teyton, L. (2007). The biology of NKT cells. Annu. Rev. Immunol. 25, 297–336.
Chackerian, A., Alt, J., Perera, V., and Behar, S.M. (2002). Activation of NKT cells protects Mice from tuberculosis. Infect. Immun. 70, 6302–6309.
Chevalier, M.S., Daniels, G.M., and Johnson, D.C. (2002). Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J. Virol. 76, 8265–8275.
Cho, S., and Jun, Y. (2011). Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation. Biochem. Biophys. Res. Commun. 413, 616–622.
Cho, S., and Hwang, E.S. (2012). Status of mTOR activity may phenotypically differentiate senescence and quiescence. Mol. Cells 33, 597–604.
Cohen, N.R., Garg, S., and Brenner, M.B. (2009). Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1–94.
De Santo, C., Salio, M., Masri, S.H., Lee, L.Y., Dong, T., Speak, A.O., Porubsky, S., Booth, S., Veerapen, N., Besra, G.S., et al. (2008). Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036–4048.
Dougan, S.K., Salas, A., Rava, P., Agyemang, A., Kaser, A., Morrison, J., Khurana, A., Kronenberg, M., Johnson, C., Exley, M., et al. (2005). Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529–539.
Furman, M.H., Ploegh, H.L., and Schust, D.J. (2000). Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? Hum. Immunol. 61, 1169–1176.
Gewurz, B.E., Gaudet, R., Tortorella, D., Wang, E.W., Ploegh, H.L., and Wiley, D.C. (2001). Antigen presentation subverted: structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc. Natl. Acad. Sci. USA 98, 6794–6799.
Gewurz, B.E., Ploegh, H.L., and Tortorella, D. (2002). US2, a human cytomegalovirus-encoded type I membrane protein, contrains a non-cleavable amino-terminal signal peptide. J. Biol. Chem. 277, 11306–11313.
Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., Van Kaer, L., Koezuka, Y., et al. (2000). alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97, 8461–8466.
Grubor-Bauk, B., Simmons, A., Mayrhofer, G., and Speck, P.G. (2003). Impared clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J. Immunol. 170, 1430–1434.
Hansen, T.H., Huang, S., Arnold, P.L., and Fermont, D.H. (2007). Patterns of nonclassical MHC antigen presentation. Nat. Immunol. 8, 563–568.
Ilyinskii, P.O., Wang, R., Balk, S.P., and Exley, M.A. (2006). CD1d mediates T-cell-Dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. J. Virol. 80, 7146–7158.
Jayawardena-Wolf, J., Benlagha, K., Chiu, Y.H., Mehr, R., and Bendelac, A. (2001). CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897–908.
Johnson, T.R., Hong, S., Van Kaer, L., Koezuka, Y., and Graham, B.S. (2002). NKT cells contribute to expansion of CD8+ T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294–4303.
Kakimi, K., Guidotti, L.G., Koezuka, Y., and Chisari, F.V. (2000). Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921–930.
Kang, S.J., and Cresswell, P. (2002). Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 277, 44838–44844.
Kawana, K., Quayle, A.J., Ficarra, M., Ibana, J.A., Shen, L., Kawana, Y., Yang, H., Marrero, L., Yavagal, S., Greene, S.J., et al. (2007). CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J. Biol. Chem. 282, 7368–7375.
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997). CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629.
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998). Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 95, 5690–5693.
Kim, H.S., Garcia, J., Exley, M., Johnson, K.W., Balk, S.P., and Blumberg, R.S. (1999). Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J. Biol. Chem. 274, 9289–9295.
Kim, E.M., Lee, H.H., Kim, S.H., Son, Y.O., Lee, S.J., Han, J., Bae, J., Kim, S.J., Park, C.G., Park, Y., et al. (2011). The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus. Mol. Immunol. 48, 2189–2197.
Körner, H., and Burgert, H.G. (1994). Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J. Virol. 68, 1442–1448.
Lee, J.H., Rho, S.B., Park, S.Y., and Chun, T. (2008). Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22. FEBS Lett. 582, 1210–1218.
Lin, Y., Roberts, T.J., Spence, P.M., and Brutkiewicz, R.R. (2005). Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J. Leukoc. Biol. 77, 151–158.
Moody, D.B., Zajonc, D.M., and Wilson, I.A. (2005). Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 5, 387–399.
Park, S.H., Roark, J.H., and Bendelac, A. (1998). Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160, 3128–3134.
Pinto, A.K., and Hill, A.B. (2005). Viral interference with antigen presentation to CD8+ T cells, lessons from cytomegalovirus. Viral Immunol. 18, 434–444.
Ploegh, H.L. (1998). Viral strategies of immune evasion. Science 280, 249–253.
Raftery, M.J., Hitzler, M., Winau, F., Giese, T., Plachter, B., Kaufmann, S.H., and Schonrich, G. (2008). Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 82, 4308–4319.
Rodgers, J.R., and Cook, R.G. (2005). MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5, 459–471.
Sanchez, D.J., Gumperz, J.E., and Ganem, D. (2005). Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115, 1369–1378.
Schust, D.J., Tortorella, D., Seebach, J., Phan, C., and Ploegh, H.L. (1998). Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188, 497–503.
Seriger, B., Ritz, U., and Ferrone, S. (2006). Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int. J. Cancer 118, 129–138.
Storkus, W.J., Howell, D.N., Salter, R.D., Dawson, J.R., and Cresswell, P. (1987). NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138, 1657–1659.
Tomazin, R., Boname, J., Hegde, N.R., Lewinsohn, D.M., Altschuler, Y., Jones, T.R., Cresswell, P., Nelson, J.A., Riddell, S.R., and Johnson, D.C. (1999). Cytomegalovirus US2 destroys two components of the MHC class II pathways, preventing recognition by CD4+ T cells. Nat. Med. 5, 1039–1043.
van Dommelen, S.L., Tabarias, H.A., Smyth, M.J., and Degli-Esposti, M.A. (2003). Activation of NKT cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77, 1877–1894.
Wang, B., Geng, Y.B., and Wang, C.R. (2001). CD1-restricted NKT cells protect nonobese Diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320.
Wiertz, E.J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T.R., Rapoport, T.A., and Ploegh, H.L. (1996). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384, 432–438.
Yang, J.Q., Chun, T., Liu, H., Hong, S., Bui, H., Van Kaer, L., Wang, C.R., and Singh, R.R. (2004). CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Eur. J. Immunol. 34, 1723–1732.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Han, J., Rho, S.B., Lee, J.Y. et al. Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity. Mol Cells 36, 455–464 (2013). https://doi.org/10.1007/s10059-013-0221-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-013-0221-8